Last reviewed · How we verify
MC2-01 vehicle
No mechanism of action is available for MC2-01 vehicle.
At a glance
| Generic name | MC2-01 vehicle |
|---|---|
| Sponsor | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
No information is available to provide a deeper explanation of the mechanism.
Approved indications
Common side effects
Key clinical trials
- A Phase III Trial To Evaluate The Efficacy And Safety Of MC2-01 Cream Compared To CAL/BDP Gel and Vehicle In Plaque Psoriasis Subjects (PHASE3)
- A Clinical Trial Evaluating Efficacy and Safety of MC2-01 Cream (PHASE3)
- This Trial is a Randomised, Multicentre, Investigator-blind, Vehicle and Comparator-controlled, Parallel-group Trial With the Purpose of Evaluation Efficacy, Safety and Convenience of the MC2-01 Cream (PHASE3)
- Evaluation of Potential Development of Photoallergic Skin Reaction After Use of MC2-01 Cream (PHASE1)
- Evaluation of Potential Phototoxicity Skin Reaction After Use of MC2-01 Cream (PHASE1)
- Evaluation of the Vasoconstriction Properties of MC2-01 Cream (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |